Baseline patient demographics for TETRIS, a prospective, non-interventional study to characterize the use of triple therapy for COPD in Germany

被引:0
|
作者
Clausen, J. [1 ]
Hennig, M. [2 ]
Paulsson, T. [3 ]
Vogelmeier, C. [4 ]
Beeh, K. [5 ]
Watz, H. [6 ]
Kardos, P. [7 ]
Rohde, G. [8 ]
Koeneke, E. [2 ]
Welte, T. [9 ]
机构
[1] Glaxosmithkline Gmbh Med, Munich, Germany
[2] Gsk Deutschland, Munich, Germany
[3] Gsk Brentford, Brentford, England
[4] Philipps Univ Marburg, Dept Med Pulm & Crit Care Med, Innere Med Klin, Schwerpunkt Pneumol, Marburg, Germany
[5] Insaf Inst Atemwegsforsch GmbH, Insaf Resp Res Inst, Wiesbaden, Germany
[6] Lungenclin Grosshansdorf, Pneumol Forschungsinst, Pulm Res Inst, Grosshansdorf, Germany
[7] Lungenpraxis Maingau Krankenhaus, Grosshansdorf, Germany
[8] Univ Klinikum Frankfurt, Med Klin 1, Schwerpunkt Pneumol, Allergol, Frankfurt, Germany
[9] Klin Pneumol, Grosshansdorf, Germany
来源
PNEUMOLOGIE | 2023年 / 77卷
基金
芬兰科学院;
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Po 283
引用
收藏
页码:S65 / S66
页数:2
相关论文
共 50 条
  • [1] Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany
    Vogelmeier, Claus F.
    Beeh, Kai-Michael
    Kardos, Peter
    Paulsson, Thomas
    Rohde, Gernot
    Watz, Henrik
    Compton, Chris
    Mohan, Tharishini
    Claussen, Jing
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
  • [2] Prospective, non-interventional study to characterise use of triple therapy for COPD: TETRIS
    Kardos, Peter
    Vogelmeier, Claus
    Beeh, Kai-Michael
    Claussen, Jing
    Paulsson, Thomas
    Rohde, Gernot
    Watz, Henrik
    Sharma, Raj
    Compton, Chris
    Mohan, Tharishini
    Welte, Tobias
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [3] A Prospective Non-Interventional Study in COPD Patients That Evolve to Fixed LABA/LAMA/ICS Triple Therapy (TRIVOLVE)
    Brusselle, G. G.
    Himpe, U.
    Haerens, M.
    Fievez, P.
    Leduc, D.
    Peche, R.
    Vanderhelst, E.
    Rommes, B.
    Geelissen, S.
    Gesquiere, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [4] The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods
    Kardos, Peter
    Vogelmeier, Claus
    Buhl, Roland
    Criee, Carl-Peter
    Worth, Heinrich
    BMC PULMONARY MEDICINE, 2015, 15
  • [5] The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods
    Peter Kardos
    Claus Vogelmeier
    Roland Buhl
    Carl-Peter Criée
    Heinrich Worth
    BMC Pulmonary Medicine, 15
  • [6] TRICOP - Non-interventional study with the first fixed triple therapy in extrafine formulation in COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 (19-20) : 515 - 516
  • [7] Ellithe: A prospective non-interventional Study to Assess the Quality of Life and Symptoms in COPD Patients receiving LAMA/LABA/ICS Triple Therapy
    Beeh, M. K.
    Scheithe, K.
    Brinkmann, R.
    PNEUMOLOGIE, 2022, 76 : S4 - S4
  • [8] Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD
    Marth, Katharina
    Schuller, Elisabeth
    Pohl, Wolfgang
    RESPIRATORY MEDICINE, 2015, 109 (05) : 616 - 624
  • [9] Two Years in the Life of a COPD Patient: Results of the non-interventional DACCORD Study
    Worth, Heinrich
    Buhl, Roland
    Criee, Carl-Peter
    Kardos, Peter
    Mailaender, Claudia
    Lossi, Nadine
    Vogelmeier, Claus
    INTERNIST, 2017, 58 : S37 - S37
  • [10] Extrafine single inhaler triple therapy effect on health status, lung function and adherence in COPD patients: A Panhellenic prospective non-interventional study - The TRIBUNE study
    Porpodis, Konstantinos
    Bartziokas, Konstantinos
    Chatziapostolou, Panagiotis
    Korkontzelou, Aliki
    Katerelos, Panos
    Efstathopoulos, Petros
    Bakakos, Petros
    RESPIRATORY MEDICINE, 2023, 212